Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity

SÃO PAULO -- Following a US$ 3 million seed investment in 2022, Nintx (Next Innovative Therapeutics), a biotech company researching and developing treatments for multifactorial diseases using Brazil’s biodiversity, has just raised an additional US$ 10 million. Read More

Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity

Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity

Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity

Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity
Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute